These funds will focus on providing loans to lower middle-market businesses with EBITDA ranging from $3 million to $25 million.
1 min read · 16 October 2023
The all-cash transaction has an enterprise value of about $3.1 billion, including the assumption of debt.
2 min read · 16 October 2023
The round was backed by Canadian investors Lumira Ventures and adMare BioInnovations, which previously invested in the company in 2021.
2 min read · 16 October 2023
The round was backed by Eniac, Craft Ventures, Vaynerfund, Sierra Ventures and Leaders Fund.
2 min read · 16 October 2023
NexPhase Capital Fund V will target lower middle-market growth-oriented companies in North America across the healthcare, software and consumer industry sectors.
1 min read · 16 October 2023
With this deal, Aquarian is replacing Reverence Capital, which has been an investor since 2019.
1 min read · 16 October 2023
FMI Capital Advisors and Fultz Maddox Dickens PLC provided legal advice to SHA while Latham & Watkins LLP acted as legal advisor to Godspeed Capital.
1 min read · 16 October 2023
Wavelynx will remain an independent business.
1 min read · 16 October 2023
The fund's backers are new and existing ABS investors.
2 min read · 13 October 2023
The seller was HealthEdge Investment Partners.
1 min read · 13 October 2023